TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
Special Notice from Department of Energy.
Data as of Oct 24, 2026. Sources: SAM.gov and Grants.gov. Snapshot govcon-directory-20261024T104923Z-2151694.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Counts and totals are computed by DSE from public SAM.gov and Grants.gov notices. Text from Grants.gov may be shortened or have contact details removed. The original notice on Grants.gov is the authoritative version.
Closing in 53 days
Notice details
- Agency
- Department of Energy
- Sub-tier agency
- ENERGY, DEPARTMENT OF
- Notice type
- Special Notice
- Solicitation number
- S-195061
- Product/service code
- AJ13
- Place of performance
- Los Alamos, New Mexico
- Posted
- Jun 16, 2026
- Response deadline
- Dec 16, 2026
- Source
- SAM.gov
Description
DC Recruiter: Broad-Spectrum Immune Enhancer from scientists at Los Alamos National Laboratory offers a differentiated approach to multi-pathogen infection prevention by using a self-assembling peptide nanofiber to recruit and activate dendritic cells (DCs), the immune system�s natural sentinels. Unlike pathogen-specific vaccines or therapeutics, it is designed to help trigger an early immune response regardless of the infecting agent. Its needle-free, spray-friendly concept adds practicality. The Challenge: DC Recruiter addresses a persistent and highly consequential gap in infection management: the need for a rapid, broadly effective way to stimulate immune defense before the specific pathogen is known. In many exposure scenarios, the body encounters a threat before clinicians can identify the cause, and that delay can reduce the effectiveness of conventional interventions. Current vaccines, antibiotics and antivirals are generally designed to act against a known target, which limits their usefulness when exposure is unexpected, diagnosis is delayed or the pathogen is unfamiliar. That limitation creates a clear unmet need for a fast-acting, broad-spectrum approach that can be deployed early, with minimal complexity, and in settings where rapid response matters most, including outbreak situations, field environments and other high-risk conditions. Problems Solved: DC Recruiter solves this problem by using a specific peptide selected to bind to dendritic cells. By leveraging
Summarized from the official notice. The description is shortened; read the full text on the official notice.
Official notice
Requirements and amendments are controlled by the official notice.
DSE verdict
The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.
See DSE GovCon plans →Similar open notices
- TIDAL: Target-Induced Droplet Assembly of LigandsClosing in 46 days
- TECHNOLOGY LICENSING OPPORTUNITY: NanoFETClosing in 55 days
- TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via CondensationClosing in 60 days
- TECHNOLOGY LICENSING OPPORTUNITY: SignalGenClosing in 149 days
Get free alerts
Email alerts for notices like this one are free on DSE GovCon Intelligence.
Set up free alerts →Frequently asked questions
When is the response deadline?
The published deadline is Dec 16, 2026. That is 53 days after the data date.
What NAICS code applies?
NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology).
Which agency issued this notice?
Department of Energy.
Where is the official notice?
The link under Official notice opens the source listing.